NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ) closed at $20.19 on October 13, 2026, down 4.99% on the day. The stock trades 52.2% below its 52-week high of $42.21 and 0.7% above its 52-week low of $20.04. Over the past year, it lost 46.7%. NewAmsterdam Pharma Company N.V. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -6.42% | -9.70% | -34.98% | -41.78% | -46.67% |
In 252 trading sessions since October 13, 2025, NAMS closed higher on 120 days (48%). Its best day was May 7, 2026 (+12.46%) and its worst was September 9, 2026 (-11.08%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.
NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.
Find more stocks like NAMS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.